期刊
MICROCIRCULATION
卷 20, 期 6, 页码 544-554出版社
WILEY-BLACKWELL
DOI: 10.1111/micc.12054
关键词
ischemia; reperfusion; stroke; curcuminoids; neutrophil; endothelium
资金
- Arizona Biomedical Research Commission (ABRC) [0920]
- National Institute of Nursing Research at the National Institutes of Health (NIH) [P20NR007794]
- Hudson/Lovaas Endowment
- National Center for Complementary and Alternative Medicine [P50AT000474]
- Office of Dietary Supplements of the National Institutes of Health
Objective: We sought to test the hypothesis that turmeric-derived curcuminoids limit reperfusion brain injury in an experimental model of stroke via blockade of early microvascular inflammation during reperfusion. Methods: Male Sprague Dawley rats subjected to MCAO/R were treated with turmeric-derived curcuminoids (vs. vehicle) 1 hour prior to reperfusion (300 mg/kg ip). Neutrophil adhesion to the cerebral microcirculation and measures of neutrophil and endothelial activation were assayed during early reperfusion (0-4 hours); cerebral infarct size, edema, and neurological function were assessed at 24 hours. Curcuminoid effects on TNFa-stimulated human brain microvascular endothelial cell (HBMVEC) were assessed. Results: Early during reperfusion following MCAO, curcuminoid treatment decreased neutrophil rolling and adhesion to the cerebrovascular endothelium by 76% and 67% and prevented > 50% of the fall in shear rate. The increased number and activation state (CD11b and ROS) of neutrophils were unchanged by curcuminoid treatment, while increased cerebral expression of TNFa and ICAM-1, a marker of endothelial activation, were blocked by > 30%. Curcuminoids inhibited NF-jB activation and subsequent ICAM-1 gene expression in HBMVEC. Conclusion: Turmeric-derived curcuminoids limit reperfusion injury in stroke by preventing neutrophil adhesion to the cerebrovascular microcirculation and improving shear rate by targeting the endothelium.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据